These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36697312)

  • 1. Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics.
    Joshi K; Rumpler E; Kennedy-Shaffer L; Bosan R; Lipsitch M
    Vaccine; 2023 Mar; 41(11):1864-1874. PubMed ID: 36697312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative performance of between-population vaccine allocation strategies with applications for emerging pandemics.
    Joshi K; Rumpler E; Kennedy-Shaffer L; Bosan R; Lipsitch M
    medRxiv; 2022 Jul; ():. PubMed ID: 34212161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of health-oriented cross-regional allocation strategies for the COVID-19 vaccine: a mathematical modelling study.
    Yang T; Deng W; Liu Y; Deng J
    Ann Med; 2022 Dec; 54(1):941-952. PubMed ID: 35393922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constructing an ethical framework for priority allocation of pandemic vaccines.
    Fielding J; Sullivan SG; Beard F; Macartney K; Williams J; Dawson A; Gilbert GL; Massey P; Crooks K; Moss R; McCaw JM; McVernon J
    Vaccine; 2021 Jan; 39(5):797-804. PubMed ID: 33408013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing two-dose vaccine resource allocation to combat a pandemic in the context of limited supply: The case of COVID-19.
    Zhu J; Wang Q; Huang M
    Front Public Health; 2023; 11():1129183. PubMed ID: 37168073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mathematical model for prioritization of individuals to receive vaccine considering governmental health protocols.
    Shamsi Gamchi N; Esmaeili M
    Eur J Health Econ; 2023 Jun; 24(4):633-646. PubMed ID: 35900675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential allocation of vaccine to control an infectious disease.
    Rao IJ; Brandeau ML
    Math Biosci; 2022 Sep; 351():108879. PubMed ID: 35843382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal spatial evaluation of a pro rata vaccine distribution rule for COVID-19.
    Castonguay FM; Blackwood JC; Howerton E; Shea K; Sims C; Sanchirico JN
    Sci Rep; 2023 Feb; 13(1):2194. PubMed ID: 36750592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach.
    Kim D; Pekgün P; Yildirim İ; Keskinocak P
    Vaccine; 2021 Nov; 39(47):6876-6882. PubMed ID: 34688498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the United States COVID-19 vaccine allocation strategy.
    Islam MR; Oraby T; McCombs A; Chowdhury MM; Al-Mamun M; Tyshenko MG; Kadelka C
    PLoS One; 2021; 16(11):e0259700. PubMed ID: 34788345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study.
    Foy BH; Wahl B; Mehta K; Shet A; Menon GI; Britto C
    Int J Infect Dis; 2021 Feb; 103():431-438. PubMed ID: 33388436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical allocation of COVID-19 vaccine in the United States: an evaluation of competing frameworks for the current pandemic and future events.
    Lawrence C; Vick DJ; Maryon T; Kerr BJ
    J Public Health Policy; 2022 Jun; 43(2):234-250. PubMed ID: 35140363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA Vaccines: A Suitable Platform for Tackling Emerging Pandemics?
    Sandbrink JB; Shattock RJ
    Front Immunol; 2020; 11():608460. PubMed ID: 33414790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal allocation of limited vaccine to control an infectious disease: Simple analytical conditions.
    Rao IJ; Brandeau ML
    Math Biosci; 2021 Jul; 337():108621. PubMed ID: 33915160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equitable and effective vaccine access considering vaccine hesitancy and capacity constraints.
    Sengul Orgut I; Freeman N; Lewis D; Parton J
    Omega; 2023 Oct; 120():102898. PubMed ID: 37275337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An agent-based model to assess large-scale COVID-19 vaccination campaigns for the Italian territory: The case study of Lombardy region.
    Cattaneo A; Vitali A; Mazzoleni M; Previdi F
    Comput Methods Programs Biomed; 2022 Sep; 224():107029. PubMed ID: 35908330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
    Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF
    BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing two-dose COVID-19 vaccine rollouts with limited supply: Operations strategies for distributing time-sensitive resources.
    Mak HY; Dai T; Tang CS
    Prod Oper Manag; 2022 Oct; ():. PubMed ID: 36246547
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.